Articles

These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher. More

The market has clearly voted against what it views as a wrong move made by NextEra's management team as NEE stock dips. More

While some stocks are all over the news, these buy-rated stocks offer high returns due to their strong fundamentals. More

Like diamonds in the rough, these undervalued stocks possess the potential to shine brightly in an investment portfolio. More

The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar. More

Although Lucid Group announced a milestone achievement with its new facility, LCID stock still presents a credibility challenge. More

These are the OTC stocks to buy for multibagger returns as they represent quality business at attractive valuation. More

Subscriber Sign in